Data / Form D filings / PIROUETTE PHARMA INC.
PIROUETTE PHARMA INC.: Form D filings
PIROUETTE PHARMA INC., a pharmaceuticals company in Portsmouth, NH, filed 5 Form D notices with the SEC between 2021 and 2026. The latest, on March 18, 2026, reports $1.1 million sold of a $6 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 200 INTERNATIONAL DRIVE STE 170 - 180, Portsmouth, NH, 03801
- Phone
- (617) 545-4768
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1870611
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 18, 2026 | New notice | $6,000,000 | $1,080,537 | $4,919,463 | 1 | Mar 10, 2026 | sec.gov |
| Apr 1, 2025 | New notice | $3,500,000 | $2,350,000 | $1,150,000 | 1 | Mar 28, 2025 | sec.gov |
| Jun 15, 2022 | New notice | $15,000,000 | $2,550,000 | $12,450,000 | 2 | May 31, 2022 | sec.gov |
| Sep 2, 2021 | New notice | $10,570,765 | $6,950,000 | $3,620,765 | 29 | Aug 19, 2021 | sec.gov |
| Jul 6, 2021 | New notice | $1,250,000 | $1,025,000 | $225,000 | 8 | Jun 21, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| CONOR CULLINANE | Executive Officer, Director, Promoter | |
| JOSEPH NEMMERS | Director | |
| PARINAZ MOTAMEDY | Director | |
| MATTHEW KANE | Executive Officer, Director, Promoter | |
| ELIJAH KAPAS | Executive Officer, Promoter |
Every Form D from the week of Mar 16, 2026 · All recent filings in New Hampshire · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what PIROUETTE PHARMA INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.